EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudie

A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment

Zhao-Hui Ding, Yu Huang, Jin-Nan Chen, Lai-Sheng Luo, Wei Zhang, Xiao Liang, Hong Lu iD

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad020 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Zhao-Hui Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medici…. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives High-dose dual therapy [proton pump inhibitor (PPI) + amoxicillin] is recommended as a Helicobacter pylori rescue treatment. However, its efficacy is still controversial. The aim of this study was to evaluate the efficacy and safety of triple therapy containing high dose of PPI and amoxicillin plus metronidazole compared with dual therapy in rescue treatment.

Methods

Two hundred and sixty-eight patients who failed at least two courses of H. pylori treatment were recruited and randomly allocated into two 14-day groups: esomeprazole 40 mg twice daily and amoxicillin 1000 mg three times daily plus metronidazole 400 mg three times daily (EAM group); or esomeprazole 40 mg twice daily and amoxicillin 1000 mg three times daily (EA group). The agar-dilution method was performed as an antibiotic susceptibility test. The 13C urea breath test was used to assess H. pylori eradication at 6 weeks after the treatment. The study was registered at clinicaltrials.gov (NCT04024527).

Results

H. pylori eradication rates in the EAM group were 85.8% (115/134, 95% CI 79.9%–91.7%) in ITT analysis and 92.6% (113/122, 95% CI 87.9%–97.3%) in PP analysis, significantly higher than those of the EA group, which were 73.1% (98/134, 95% CI 65.6%–80.6%) and 83.1% (98/118, 95% CI 76.8%–89.8%) (P = 0.005, 0.011). Resistance rates of amoxicillin and metronidazole were 6.6% (13/196) and 89.8% (176/196). Metronidazole resistance did not affect the eradication rates in the EAM group. Both groups had similar moderate and severe adverse events and similar compliance.

Conclusions

A triple therapy containing high dose of PPI and amoxicillin plus metronidazole could be a potential rescue therapy worldwide even in a high metronidazole-resistance region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsHumansMetronidazoleAnti-Bacterial AgentsEsomeprazoleDrug Therapy, CombinationAmoxicillinProton Pump InhibitorsTreatment OutcomeClarithromycin

Substanzen

MetronidazoleAnti-Bacterial AgentsEsomeprazoleAmoxicillinProton Pump InhibitorsClarithromycin

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai, China.

ORCID-Profile: Hong Lu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ding, Z. H., Huang, Y., Chen, J. N., Luo, L. S., Zhang, W., Liang, X., & Lu, H. (2023). A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad020

Vancouver

Ding ZH, Huang Y, Chen JN, Luo LS, Zhang W, Liang X, et al. A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad020

BibTeX
@article{Ding2023,
  author = {Ding, Zhao-Hui and Huang, Yu and Chen, Jin-Nan and Luo, Lai-Sheng and Zhang, Wei and Liang, Xiao and Lu, Hong},
  title = {A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad020}
}
Kostenlos starten →